代谢相关脂肪性肝病发病机理及治疗的研究进展
Progress in the pathogenesis and treatment of metabolic associated fatty liver disease
谢淑雅 1曹名波2
作者信息
- 1. 河南大学人民医院河南省人民医院消化内科,河南郑州 450000
- 2. 河南大学人民医院河南省人民医院消化内科,河南郑州 450000;郑州大学人民医院河南省人民医院消化内科
- 折叠
摘要
非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是一种以肝内脂质沉积为特征的慢性肝病,目前已更名为代谢相关脂肪性肝病(metabolic associated fatty liver disease,MAFLD).近年来MAFLD发病率逐步提升,对医疗系统的负担持续增加,在治疗方面尚无特效药物.本研究通过查阅相关文献,概述了影响MAFLD发病的相关机制,归纳了 MAFLD治疗方法的当前进展,为临床治疗MAFLD提供理论基础.
Abstract
Non-alcoholic fatty liver disease(NAFLD)is a very common chronic liver disease that has been renamed metabolic associated fatty liver disease(MAFLD).In recent years,the incidence of MAFLD has gradually increased,and the burden on the medical system has continued to increase.Currrently,there is no specific treatment for MAFLD.This study outlined the relevant mechanisms used to affect the pathogenesis of MAFLD,summarized the current progress in the treatment of MAFLD,which provided a theoretical basis for the clinical treatment of MAFLD.
关键词
代谢相关脂肪性肝病/非酒精性脂肪性肝病/发病机理/治疗Key words
Metabolic associated fatty liver disease/Non-alcoholic fatty liver disease/Pathogenesis/Treatment引用本文复制引用
出版年
2024
NETL
NSTL
万方数据